Kyverna Therapeutics
KYVERNA is pioneering a new class of treatments and potential cures for serious autoimmune diseases. The company's therapeutic platform combines advanced T-cell engineering and synthetic biology technologies to suppress and eliminate the autoreactive immune cells at the root cause of inflammatory diseases.
Domain
kyvernatx.com
Country
United StatesIndustry
BiotechnologyEmployees
101-250
Last Funding
$100.0M
Founded
2017
Tech Stack (18 technologies)
Frequently Asked Questions
What technologies does Kyverna Therapeutics use?+
Kyverna Therapeutics uses 18 technologies including Divi, Google Analytics, Google Tag Manager.
What industry is Kyverna Therapeutics in?+
Kyverna Therapeutics operates in the Biotechnology industry.
Where is Kyverna Therapeutics based?+
Kyverna Therapeutics is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026